Cardiovascular Journal of Africa: Vol 23 No 10 (November 2012) - page 36

CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 10, November 2012
562
AFRICA
48.
Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy.
Lancet
2006;
368
: 687–693.
49.
Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardio-
myopathy: a systematic review.
Int J Cardiol
2009;
131
: 168–179.
50.
Fett JD. Peripartum cardiomyopathy. Insights from Haiti regarding a
disease of unknown etiology.
Minn Med
2002;
85
: 46–48.
51.
Sanderson JE, Adesanya CO, Anjorin FI, Parry EH. Postpartum cardiac
failure – heart failure due to volume overload?
Am Heart J
1979;
97
:
613–621.
52.
Ford L, Abdullahi A, Anjorin FI,
et al
.
The outcome of peripartum
cardiac failure in Zaria, Nigeria.
Q J Med
1998;
91
: 93–103.
53.
Adesanya CO, Anjorin FI, Adeoshun IO, Davidson NM, Parry EH.
Peripartum cardiac failure. A ten year follow-up study.
Trop Geogr Med
1989;
41
: 190–196.
54.
Davidson NM, Parry EH. Peri-partum cardiac failure.
Q J Med
1978;
47
: 431–461.
55.
Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy:
recent insights in its pathophysiology.
Trends Cardiovasc Med
2008;
18
: 173–179.
56.
Hilfiker-Kleiner D, Kaminski K, Podewski E,
et al
.
A cathepsin
D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyo-
pathy.
Cell
2007;
128
: 589–600.
57.
Sliwa K, Blauwet L, Tibazarwa K,
et al
.
Evaluation of bromocriptine in
the treatment of acute severe peripartum cardiomyopathy: a proof-of-
concept pilot study.
Circulation
2010;
121
: 1465–1473.
58.
Hu CL, Li YB, Zou YG,
et al.
Troponin T measurement can predict
persistent left ventricular dysfunction in peripartum cardiomyopathy.
Heart
2007;
93
: 488–490.
59.
Caballero-Borrego J, Garcia-Pinilla JM, Rueda-Calle E, de Teresa-
Galvan E. [Evidence of gadolinium late-enhancement on cardiac
magnetic resonance imaging in a patient with peripartum cardiomyopa-
thy].
Revista espanol Cardiol
2008;
61
: 219–220.
60.
Kawano H, Tsuneto A, Koide Y,
et al
.
Magnetic resonance imaging
in a patient with peripartum cardiomyopathy.
Int Med
(
Tokyo, Japan)
2008;
47
: 97–102.
61.
Kuhl U, Pauschinger M, Seeberg B,
et al.
Viral persistence in
the myocardium is associated with progressive cardiac dysfunction.
Circulation
2005;
112
: 1965–1970.
62.
Rabausch-Starz I, Schwaiger A, Grunewald K, Muller-Hermelink HK,
Neu N. Persistence of virus and viral genome in myocardium after
coxsackievirus B3-induced murine myocarditis.
Clin Exp Immunol
1994; 96: 69–74.
63.
Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R. High
prevalence of viral genomes and inflammation in peripartum cardio-
myopathy.
Am J Obstet Gynecol
2005;
193
: 363–365.
64.
Cenac A, Gaultier Y, Devillechabrolle A, Moulias R. Enterovirus infec-
tion in peripartum cardiomyopathy
.
Lancet
1988;
2
: 968–969.
65.
O’Connell JB, Costanzo-Nordin MR, Subramanian R,
et al.
Peripartum
cardiomyopathy: clinical, hemodynamic, histologic and prognostic
characteristics.
J Am Coll Cardiol
1986;
8
: 52–56.
66.
Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL.
Peripartum myocarditis and cardiomyopathy.
Circulation
1990;
81
:
922–928.
67.
Owor R, Rwomushana RJ. Familial congestive cardiomyopathy in
Uganda.
East Afr Med J
1975;
52
: 372–375.
68.
Brink AJ, Torrington M, van der Walt JJ. Hereditary dysrhythmic
congestive cardiomyopathy.
S Afr Med J
1976;
50
: 2119–2123.
69.
Przybojewski JZ, van der Walt JJ, van Eeden PJ, Tiedt FA. Familial
dilated (congestive) cardiomyopathy. Occurrence in two brothers and an
overview of the literature.
S Afr Med J
1984;
66
: 26–30.
70.
Brink AJ, Torrington M. Progressive familial heart block – two types.
S
Afr Med J
1977;
52
: 53–59.
71.
Van der Merwe PL, Weymar HW, Torrington M, Brink AJ. Progressive
familial heart block. Part II. Clinical and ECG confirmation of progres-
sion – report on 4 cases.
S Afr Med J
1986;
70
: 356–357.
72.
Fernandez P, Moolman-Smook J, Brink P, Corfield V. A gene locus for
progressive familial heart block type II (PFHBII) maps to chromosome
1
q32.2-q32.3.
Hum Genet
2005;
118
: 133–137.
73.
Mayosi BM, Khogali S, Zhang B, Watkins H. Cardiac and skeletal actin
gene mutations are not a common cause of dilated cardiomyopathy.
J
Med Genet
1999;
36
: 796–797.
74.
Watkins DA, Mayosi BM. The contribution of South Africans to the
subject of dilated cardiomyopathy with reference to cardiovascular
collagenosis with parietal endocardial thrombosis: a clinicopathologic
study of forty cases.
Cardiovasc J Afr
2009;
20
: 11–16.
75.
Higginson J, Gillanders AD, Murray JF. The heart in chronic malnutri-
tion.
Br Heart J
1952;
14
: 213–24.
76.
Svoboda D, Grady H, Higginson J. The effects of chronic protein defi-
ciency in rats. II. Biochemical and ultrastructural changes.
Lab Invest
1966;
15
: 731–749.
77.
Swift PJ. Dietary iron overload as a cause of idiopathic cardiomyopathy
in South African blacks: the role of free iron radicals.
S Afr Med J
1996;
86
:
C17–C21.
78.
Davies JNP. Endocardial fibrosis in Africans.
East Afr Med J
1948;
25
: 10.
79.
William A. Heart disease in the native population of Uganda.
East Afr
Med J
1938;
15
: 279.
80.
Bukhman G, Ziegler J, Parry E. Endomyocardial fibrosis: still a
mystery after 60 years.
PLoS Negl Trop Dis
2008;
2
:
e97.
81.
Olsen EG. The role of biopsy in the diagnosis of myocarditis.
Herz
1985;
10
: 21–26.
82.
Freers J, Amandua J, Mugerwa R. Endomyocardial fibrosis and eosino-
philia.
Lancet
1993;
342
: 1233.
83.
Freers J, Masembe V, Schmauz R, Mayanja-Kizza H. Endomyocardial
fibrosis syndrome in Uganda.
Lancet
2000;
355
: 1994–1995.
84.
Freers J, Mayanja-Kizza H, Rutakingirwa M, Gerwing E. Endo-
myocardial fibrosis: why is there striking ascites with little or no periph-
eral oedema?
Lancet
1996;
347
: 197.
85.
Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH. A population study of
endomyocardial fibrosis in a rural area of Mozambique.
N Engl J Med
2008;
359
: 43–49.
86.
Abrahams DG, Barton CJ, Cockshott WP, Edington GM, Weaver EJ.
Annular subvalvular left ventricular aneurysms.
Q J Med
1962;
31
:
345–360.
87.
Edington GM, Williams AO. Left atrial aneurysms associated with
annular subvalvular left ventricular aneurysms.
J Pathol Bacteriol
1968;
96
: 273–83.
88.
Cockshott WP. Annular subvalvar left ventricular aneurysms.
Cardiologia
1968;
52
: 109–112.
1...,26,27,28,29,30,31,32,33,34,35 37,38,39,40,41,42,43,44,45,46,...64
Powered by FlippingBook